Cell-based method can predict how breast cancer patients will respond to treatments

In Uncategorized by Barbara Jacoby

Source: Karolinska Institutet From: news-medical.net Researchers at Karolinska Institutet in Sweden have developed a method that should be able to predict whether a patient with breast cancer will benefit from a particular treatment or not. The cell-based method has been tested on patients with promising results, according to a study published in PNAS. Several different drugs are currently available for …

View Post

Hormonal treatment provides long-term benefit for premenopausal women with breast cancer

In In The News by Barbara Jacoby

Source: Karolinska Institutet From: news-medical.net To investigate the long-term benefit of hormone-lowering treatment, researchers at Karolinska Institutet in Sweden have done a 20-year follow-up of premenopausal women with breast cancer. The study, published in the Journal of Clinical Oncology, indicates that the treatment provides protection even after a longer period of time and that different patients seem to benefit from …

View Post

Researchers identify a protein that protects against breast cancer growth

In In The News by Barbara Jacoby

Source: Karolinska Institutet From: news-medical.net Researchers at Karolinska Institutet in Sweden have identified a protein that protects against breast tumor growth and that can be linked to a better prognosis in breast cancer patients. The results, which are published in the journal Nature Communications, may contribute to the development of new therapies for difficult-to-treat forms of breast cancer. Breast cancer …

View Post

Breast Conservation Plus Radiation Tops Mastectomy

In Clinical Studies News by Barbara Jacoby

By: Mike Bassett From: medpagetoday.com “More extensive breast surgery does not appear to save any lives,” say Swedish researchers Breast-conserving surgery accompanied by radiotherapy (RT) gave women better survival odds than mastectomy with or without RT, according to Swedish researchers. Among nearly 50,000 women treated for T1 to T2 breast cancer, those who underwent breast-conserving surgery followed by RT achieved …

View Post

Lower dose of oestrogen receptor modulator seems to reduce risk of breast cancer

In Clinical Studies News by Barbara Jacoby

Source: Karolinska Institutet From: eurekalert.org While the drug tamoxifen reduces the risk of developing breast cancer and prevents recurrence, the side-effects cause many women to discontinue their treatment. A study involving researchers at Karolinska Institutet in Stockholm has now found that a much lower dose than the standard produces a good effect with fewer adverse reactions in women who have …